Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
Earnings Data
Report Date
Aug 18, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.05Last Year’s EPS
0.01Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: -12.50%
|Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Neutral
Rockwell Medical's earnings call showed a company in transition, focusing on expanding and diversifying its customer base amidst challenges with its largest customer. While there were positive developments in product expansion and manufacturing efficiency, the significant revenue decline and negative adjusted EBITDA due to customer transition posed major challenges.Company Guidance
During Rockwell Medical's first quarter 2025 earnings call, the company reaffirmed its guidance for fiscal year 2025, projecting net sales between $65 million and $70 million, a gross margin ranging from 16% to 18%, and an adjusted EBITDA between negative $500,000 and positive $500,000. Despite a 17% decrease in first-quarter net sales compared to the same period in 2024, due to the transition of their largest customer to a different supplier, the gross margin improved from 14% to 16%. The company also highlighted the addition of a single-use bicarbonate cartridge technology to its product portfolio, aiming to diversify offerings and capture growth in the dialysis products market. Furthermore, Rockwell Medical addressed ongoing discussions with its largest customer about potential contract extensions, while also actively pursuing new business development opportunities, both domestically and internationally. The company is confident in maintaining its guidance, with potential upside from acquiring new customers not yet factored into its current projections.New Contracts and Diversification
Rockwell Medical diversified its customer base by signing several new contracts with leading hemodialysis providers, enhancing its position as a preferred provider with high-quality products.
Manufacturing Efficiency
The company continued to consolidate and automate its manufacturing operations, reducing expenses and sustaining its gross margin within the guidance range.
Product Portfolio Expansion
Rockwell Medical added a single-use bicarbonate cartridge technology to its portfolio, targeting a fast-growing segment in the dialysis products market.
Gross Margin Improvement
Q1 2025 gross margin increased to 16%, up from 14% in the same period of 2024.
Net Loss Improvement
Net loss for Q1 2025 was $1.5 million, an improvement from a net loss of $1.7 million in Q1 2024.
RMTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RMTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $1.12 | $1.04 | -7.14% |
Mar 20, 2025 | $1.76 | $1.40 | -20.45% |
Nov 12, 2024 | $4.65 | $2.83 | -39.14% |
Aug 08, 2024 | $1.77 | $2.14 | +20.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Rockwell Medical Technologies (RMTI) report earnings?
Rockwell Medical Technologies (RMTI) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is Rockwell Medical Technologies (RMTI) earnings time?
Rockwell Medical Technologies (RMTI) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMTI EPS forecast?
RMTI EPS forecast for the fiscal quarter 2025 (Q2) is -0.05.